Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma
for Renal Cell Carcinoma
1 location in Philadelphia
Sponsor: Abramson Cancer Center at Penn Medicine
Sex: All·Age: 18+·Accepts healthy volunteers
Code: NCT05733715·EARLY_Phase 1·Recruiting